Expression of human CD46 modulates inflammation associated with GalTKO lung xenograft injury

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 1084-1095

  Burdorf, L ^a   Stoddard, T ^a   Zhang, T ^a   Rybak, E ^a   Riner, A ^a   Avon, C ^a   Laaris, A ^a   Cheng, X ^a   Sievert, E ^a   Braileanu, G ^a   Newton, A ^a   Phelps, C J ^b   Ayares, D ^b   Azimzadeh, A M ^a   Pierson III, R N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b REVIVICOR INC   (United States)

Author keywords

Coagulation; complement; ex vivo perfusion; GalTKO.hCD46; leukocyte adhesion; lung; platelet activation; xenotransplantation

Indexed keywords

ALPHA-1,3-GALACTOSYLTRANSFERASE 1, PORCINE; DECAY ACCELERATING FACTOR; EPITOPE; GALACTOSYLTRANSFERASE; HISTAMINE;

ANIMAL; BLOOD CLOTTING; COMPLEMENT ACTIVATION; ENZYME IMMUNOASSAY; GENETICS; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG INJURY; LUNG TRANSPLANTATION; METABOLISM; MINIPIG; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; BLOOD COAGULATION; COMPLEMENT ACTIVATION; EPITOPES; GALACTOSYLTRANSFERASES; GRAFT SURVIVAL; HISTAMINE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; LUNG INJURY; LUNG TRANSPLANTATION; NEUTROPHILS; SWINE; SWINE, MINIATURE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84899427018     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12673     Document Type: Article

References (43)

1. Pierson RN III, Dorling A, Ayares D, et al. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009; 16: 263-280.
2. Cooper DK, Hara H, Ezzelarab M, et al. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation. J Biomed Res 2013; 27: 249-253.
3. Byrne GW, McGregor CG., Cardiac xenotransplantation: Progress and challenges. Curr Opin Organ Transplant 2012; 17: 148-154.
4. Mohiuddin MM, Corcoran PC, Singh AK, et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant 2012; 12: 763-771.
5. Griesemer AD, Hirakata A, Shimizu A, et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009; 9: 2669-2678.
6. Ekser B, Echeverri GJ, Hassett AC, et al. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation 2010; 90: 483-493.
7. Kim K, Schuetz C, Elias N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation 2012; 19: 256-264.
8. van der Windt DJ, Bottino R, Kumar G, et al. Clinical islet xenotransplantation: How close are we ? Diabetes 2012; 61: 3046-3055.
9. Manji RA, Menkis AH, Ekser B, Cooper DK., Porcine bioprosthetic heart valves: The next generation. Am Heart J 2012; 164: 177-185.
10. McGregor CG, Carpentier A, Lila N, Logan JS, Byrne GW., Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 2011; 141: 269-275.
11. Mohiuddin MM, Corcoran PC, Singh AK, et al. Pig heart B-cell depletion extends the survival of GTKO.hCD46Tg xenografts in baboons for up to 8 months. Am J Transplant 2012; 12: 763-771.
12. Loveland BE, Milland J, Kyriakou P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004; 11: 171-183.
13. Schroeder C, Allan JS, Nguyen BN, et al. Hyperacute rejection is attenuated in GalT knockout swine lungs perfused ex vivo with human blood. Transplant Proc 2005; 37: 512-513.
14. Nguyen BN, Azimzadeh AM, Schroeder C, et al. Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection. Xenotransplantation 2011; 18: 94-107.
15. Nguyen BN, Azimzadeh AM, Zhang T, et al. Life-supporting function of genetically modified swine lungs in baboons. J Thorac Cardiovasc Surg 2007; 133: 1354-1363.
16. Bush EL, Barbas AS, Holzknecht ZE, et al. Coagulopathy in a-galactosyl transferase knockout pulmonary xenotransplants. Xenotransplantation 2011; 18: 6-13.
17. Pöling J, Oezkur M, Kogge K, Mengel M, Niemann H, Winkler M., Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins. Transpl Int 2006; 19: 225-232.
18. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008; 21: 1163-1174.
19. Westall GP, Levvey BJ, Salvaris E, et al. Sustained function of genetically modified porcine lungs in an ex vivo model of pulmonary xenotransplantation. J Heart Lung Transplant 2013; 32: 1123-1130.
20. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2004; 299: 411-414.
21. Burdorf L, Azimzadeh AM, Pierson RN III., Xenogeneic lung transplantation models. Methods Mol Biol 2012; 885: 169-189.
22. Dean PG, Cohen AJ, Dalla Valle H, et al. The effect of anti-alphaGal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival. Transplantation 2002; 74: 1596-1603.
23. Pierson RN III., Antibody-mediated xenograft injury: Mechanisms and protective strategies. Transpl Immunol 2009; 21: 65-69.
24. Gaca JG, Lesher A, Aksoy O, Ruggeri ZM, Parker W, Davis RD., The role of the porcine von Willebrand factor: Baboon platelet interactions in pulmonary xenotransplantation. Transplantation 2002; 74: 1596-1603.
25. Gaca JG, Lesher A, Aksoy O, et al. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 2002; 73: 1717-1723.
26. Gaca JG, Appel JZ III, Lukes JG, et al. Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction. Transplantation 2006; 81: 1686-1694.
27. Schröder C, Pfeiffer S, Wu G, et al. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood. J Heart Lung Transplant 2003; 22: 1365-1375.
28. Pfeiffer S, Zorn GL III, Blair KS, et al. Hyperacute lung rejection in the pig-to-human model 4: Evidence for complement and antibody independent mechanisms. Transplantation 2005; 79: 662-671.
29. Seya T, Atkinson JP., Functional properties of membrane cofactor protein of complement. Biochem J 1989; 264: 581-588.
30. Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, Atkinson JP., Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. Immunology 2002; 168: 6298-6304.
31. Byrne JG, Karavas AN, Elhalabi A, Cohn LH., Myocardial neutrophil sequestration during reperfusion of the transplanted rabbit heart. J Heart Lung Transplant 2000; 19: 786-791.
32. Pinsky DJ., The vascular biology of heart and lung preservation for transplantation. Thromb Haemost 1995; 74: 58-65.
33. Mulligan MS, Paulson JC, De Frees S, Zheng ZL, Lowe JB, Ward PA., Protective effects of oligosaccharides in P-Selectin-dependent lung injury. Nature 1993; 364: 149-151.
34. Brandl U, Michel S, Erhardt M, et al. Transgenic animals in experimental xenotransplantation models: Orthotopic heart transplantation in the pig-to-baboon model. Transplant Proc 2007; 39: 577-578.
35. Mañez R, Lopez-Pelaez E, Centeno A, et al. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation. Transplantation 2004; 78: 930-933.
36. Cooper DK, Ekser B, Burlak C, et al. Clinical lung xenotransplantation- What donor genetic modifications may be necessary ? Xenotransplantation 2012; 19: 144-158.
37. Schulte am Esch J II, Rogiers X, Robson SC., Molecular incompatibilities in hemostasis between swine and men-Impact on xenografting. Ann Transplant 2001; 6: 12-16.
38. Cowan PJ, Roussel JC, d'Apice AJ., The vascular and coagulation issues in xenotransplantation. Curr Opin Organ Transplant 2009; 14: 161-167.
39. Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d'Apice AJ, Cowan PJ., Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant 2008; 8: 1101-1112.
40. Cowan PJ., Coagulation and the xenograft endothelium. Xenotransplantation 2007; 14: 7-12.
41. Kim YT, Lee HJ, Lee SW, et al. Pre-treatment of porcine pulmonary xenograft with desmopressin: A novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation. Xenotransplantation 2008; 15: 27-35.
42. Kim HK, Kim JE, Wi HC, et al. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation. Xenotransplantation 2008; 15: 246-256.
43. Kim HK, Kim JE, Park CM, Kim YT, Han KS, Cho HI., Aurintricarboxylic acid upregulates the thrombomodulin expression of endothelial cells and peripheral blood monocytes. Blood Coagul Fibrinolysis 2008; 19: 489-494.